CORMEDIX INC. - COMMON STOCK
8.9000
04-十月-24 15:59:59
15 分钟延时
股票
+0.6100
+7.36%
今日范围
8.2800 - 9.0300
ISIN
N/A
来源
NASDAQ
-
CorMedix Inc. Announces Appointment of Chief Legal Officer
15 12月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Partnership With The Leapfrog Group
04 12月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
15 11月 2023 12:57:47 条件 Nasdaq GlobeNewswire
-
14 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
02 11月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
11 10月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
26 9月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
08 9月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
06 9月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
30 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
08 8月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
26 7月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
28 6月 2023 22:57:02 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
28 6月 2023 16:07:53 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
21 6月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
15 6月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Cormedix Inc. To Present At The Jefferies Healthcare Conference
30 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath
16 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
15 5月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
08 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire